Page 223 - IJB-9-2

International Journal of Bioprinting Three-dimensional bioprinting in toxicological research

organoids. J Hepatol, 71: 970–985. 3D bioprinting: Novel approaches for engineering complex
human tissue equivalents and drug testing. Essays Biochem,
https://doi.org/10.1016/j.jhep.2019.06.030
65: 417–427.
70. Augustyniak J, Bertero A, Coccini T, et al., 2019, Organoids
are promising tools for species-specific in vitro toxicological https://doi.org/10.1042/EBC20200153
studies. J Appl Toxicol, 39: 1610–1622. 82. Nguyen DG, Pentoney SL Jr., 2017, Bioprinted three
dimensional human tissues for toxicology and disease
https://doi.org/10.1002/jat.3815
modeling. Drug Discov Today Technol, 23: 37–44.
71. Akbari S, Arslan N, Senturk S, et al., 2019, Next-generation
liver medicine using organoid models. Front Cell Dev https://doi.org/10.1016/j.ddtec.2017.03.001
Biol, 7: 345. 83. Kryou C, Leva V, Chatzipetrou M, et al., 2019, Bioprinting
for liver transplantation. Bioengineering (Basel), 6: 95.
https://doi.org/10.3389/fcell.2019.00345
https://doi.org/10.3390/bioengineering6040095
72. Nuciforo S, Fofana I, Matter MS, et al., 2018, Organoid
models of human liver cancers derived from tumor needle 84. Tasoglu S, Demirci U, 2013, Bioprinting for stem cell
biopsies. Cell Rep, 24: 1363–1376. research. Trends Biotechnol, 31: 10–19.
https://doi.org/10.1016/j.celrep.2018.07.001 https://doi.org/10.1016/j.tibtech.2012.10.005
73. Hu H, Gehart H, Artegiani B, et al., 2018, Long-term 85. Agarwal T, Banerjee D, Konwarh R, et al., 2021, Recent
expansion of functional mouse and human hepatocytes as advances in bioprinting technologies for engineering
3D organoids. Cell, 175: 1591–1606 e1519. hepatic tissue. Mater Sci Eng C Mater Biol Appl, 123: 112013.
https://doi.org/10.1016/j.cell.2018.11.013 https://doi.org/10.1016/j.msec.2021.112013
74. Artegiani B, Clevers H, 2018, Use and application of 86. Vurat MT, Ergun C, Elcin AE, et al., 2020, 3D bioprinting of
3D-organoid technology. Hum Mol Genet, 27: R99–R107. tissue models with customized bioinks. Adv Exp Med Biol,
1249: 67–84.
https://doi.org/10.1093/hmg/ddy187
https://doi.org/10.1007/978-981-15-3258-0_5
75. Schneeberger K, Spee B, Costa P, et al., 2017, Converging
biofabrication and organoid technologies: the next frontier 87. Tandon R, Froghi S, 2020, Artificial liver support systems.
in hepatic and intestinal tissue engineering? Biofabrication, J Gastroenterol Hepatol, 36: 1164–1179.
9: 013001.
https://doi.org/10.1111/jgh.15255
https://doi.org/10.1088/1758-5090/aa6121
88. Matai I, Kaur G, Seyedsalehi A, et al., 2020, Progress in
76. Dutta D, Heo I, Clevers H, 2017, Disease modeling in stem cell- 3D bioprinting technology for tissue/organ regenerative
derived 3D organoid systems. Trends Mol Med, 23: 393–410. engineering. Biomaterials, 226: 119536.
https://doi.org/10.1016/j.molmed.2017.02.007 https://doi.org/10.1016/j.biomaterials.2019.119536
77. Leite SB, Roosens T, El Taghdouini A, et al., 2016, Novel 89. Ma L, Wu Y, Li Y, et al., 2020, Current advances on 3D-bioprinted
human hepatic organoid model enables testing of drug- liver tissue models. Adv Healthc Mater, 9: e2001517.
induced liver fibrosis in vitro. Biomaterials, 78: 1–10.
https://doi.org/10.1002/adhm.202001517
https://doi.org/10.1016/j.biomaterials.2015.11.026
90. Wang X, 2019, Advanced polymers for three-dimensional
78. Gilazieva Z, Ponomarev A, Rutland C, et al., 2020, (3D) organ bioprinting. Micromachines (Basel), 10: 814.
Promising applications of tumor spheroids and organoids https://doi.org/10.3390/mi10120814
for personalized medicine. Cancers (Basel), 12: 2727.
91. He YT, Qi YN, Zhang BQ, et al., 2019, Bioartificial liver
https://doi.org/10.3390/cancers12102727
support systems for acute liver failure: A systematic review
79. Chen EP, Toksoy Z, Davis BA, et al., 2021, 3D Bioprinting and meta-analysis of the clinical and preclinical literature.
of vascularized tissues for in vitro and in vivo applications. World J Gastroenterol, 25: 3634–3648.
Front Bioeng Biotechnol, 9: 664188.
https://doi.org/10.3748/wjg.v25.i27.3634
https://doi.org/10.3389/fbioe.2021.664188
92. Chamuleau RA, 2009, Future of bioartificial liver support.
80. Lee JM, Sing SL, Zhou M, et al., 2018, 3D bioprinting World J Gastrointest Surg, 1: 21–25.
processes: A perspective on classification and terminology. https://doi.org/10.4240/wjgs.v1.i1.21
Int J Bioprint, 4: 151.
93. Lelievre SA, Kwok T, Chittiboyina S, 2017, Architecture in
https://doi.org/10.18063/IJB.v4i2.151
3D cell culture: An essential feature for in vitro toxicology.
81. Hagenbuchner J, Nothdurfter D, Ausserlechner MJ, 2021, Toxicol In Vitro, 45: 287–295.

Volume 9 Issue 2 (2023) 215 https://doi.org/10.18063/ijb.v9i2.663